NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $9,646,053 | -40.2% | 232,435 | -13.3% | 0.01% | -33.3% |
Q1 2023 | $16,118,422 | -17.6% | 268,015 | +0.5% | 0.01% | -20.0% |
Q4 2022 | $19,558,337 | -4.7% | 266,644 | -1.3% | 0.02% | -11.8% |
Q3 2022 | $20,532,000 | +10.7% | 270,225 | +1.3% | 0.02% | +21.4% |
Q2 2022 | $18,541,000 | -13.2% | 266,777 | +3.5% | 0.01% | 0.0% |
Q1 2022 | $21,362,000 | – | 257,844 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |